Helping Togolese women plan and space their pregnancies since 1989.
- Postpartum intrauterine device (PPIUD) services are now available at 50 health care facilities in Togo, with providers ready to meet the needs of postpartum women in surrounding areas.
- More than 200 providers have been trained to provide accurate and appropriate information on postpartum family planning, including PPIUDs, to pregnant women and can refer them to a health care facility where these services are provided if they are not available at their own site.
- More than 2,510 PPIUDs have been inserted at Jhpiego-supported health care facilities for postpartum women seeking to delay their next pregnancy.
- Jhpiego Togo developed an innovative training approach to scale up services for an innovative injectable contraceptive method (depot-medroxyprogesterone acetate, also known as Sayana® Press); this approach has been used to build the capacity of 303 health care providers to provide this service. Jhpiego Togo also worked with Togo’s Ministry of Health to develop self-injection guidelines.
Our Work in Togo
Accelerating Uptake of Expanded Method Mix
Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries, including Togo.
Testing Models of DMPA-SC Introduction in Togo to Generate Lessons for Scale-Up
Jhpiego is assisting Togo’s Ministry of Health and Social Protection in the introduction, learning and scale-up of an injectable contraceptive method, subcutaneously administered depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is being introduced in Kloto District via health centers and community health workers, and in Golfe District via health centers only. Results from these two different models are expected to help inform the Ministry on further expansion. Activities under this project, funded by Family Planning 2020, include: assist the Ministry in creating a technical working group on DMPA-SC in Togo; train 10 master trainers on DMPA-SC; train 70 health center staff in counseling and administration of DMPA-SC in the two districts; train 40 community health workers and five supervisors on family planning services, including DMPA-SC, in one health district; conduct communication activities for demand creation; conduct post-training quarterly supervisory visitors for the health centers and community health workers; perform data collection and analysis on DMPA-SC; and document and share pilot results with government and partners.
Catalytic Opportunity Funds for DMPA-SC Scale-Up
With funding from the Clinton Health Access Initiative, Jhpiego is collaborating with the Ministry of Health and Social Protection to catalyze introduction of subcutaneously administered depot-medroxyprogesterone acetate (DMPA-SC) with a key emphasis on expanding self-injection. Under this project, Jhpiego is: training 42 trainers (in 28 health districts from six health regions) on administering DMPA-SC; evaluating and increasing counseling and training materials; sensitizing target groups (women of childbearing age, committed men and youths) and the general population to generate demand for DMPA-SC, especially self-injection; strengthening the capacity of 1,405 providers in 703 public and private health facilities, as well as 52 schools and university infirmaries, to offer DMPA-SC; and promoting self-injection in 33 districts.